Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology
Open Access
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 8 (1) , 15-23
- https://doi.org/10.1186/cc2338
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Terlipressin-Ephedrine Versus Ephedrine to Treat Hypotension at the Induction of Anesthesia in Patients Chronically Treated with Angiotensin Converting-Enzyme Inhibitors: A Prospective, Randomized, Double-Blinded, Crossover StudyAnesthesia & Analgesia, 2002
- Use of nitric oxide synthase inhibitors to treat septic shockCritical Care Medicine, 1999
- An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shockCritical Care Medicine, 1999
- Cardiovascular Effects of Conventional Sulfonylureas and GlimepirideHormone and Metabolic Research, 1996
- Arginine Vasopressin-lnduced Renal Vasodilation Mediated by Nitric OxideJournal of Vascular Research, 1995
- Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response.Journal of Clinical Investigation, 1994
- Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo.Stroke, 1993
- Cellular mechanism of endothelin-1 release by angiotensin and vasopressin.Hypertension, 1991
- Interaction of arginine vasopressin and angiotensin II on Ca2+ in vascular smooth muscle cellsKidney International, 1990
- Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes InsipidusNew England Journal of Medicine, 1988